ArticleRadiation research2026
A Novel Bioluminescence Tomography System Compatible with CBCT-guided Small Animal Irradiators for High-Precision Preclinical Radiation Research.
Article in Radiation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Widely used cone-beam computed tomography (CBCT)-guided irradiators struggle to localize soft-tissue targets due to low imaging contrast. While bioluminescence tomography (BLT) offers a promising functional imaging solution, its adoption in pre-clinical radiotherapy research has been limited. To address this, we developed MuriGlo, a novel BLT system compatible with CBCT-guided small animal irradiators to support high-precision radiation studies. We demonstrate MuriGlo's capabilities in supporting both in vitro and in vivo experiments. MuriGlo consists of a detachable mouse bed, thermostatic control, mirrors, filters, and a charge-coupled device (CCD) camera, enabling multi-projection and multi-spectral bioluminescence imaging (BLI). The detachable bed facilitates animal transfer between MuriGlo and an irradiator for BLT-guided radiation study. We evaluated the thermostatic control's ability and demonstrated that it can maintain a consistent animal body temperature at 37°C throughout imaging. We also quantified detection sensitivity via signal-to-noise ratio (SNR) in detecting minimal cell quantities using glioblastoma (GL261) cells with Luc2 and AkaLuc reporters. The optical system can detect as few as 1173 GL261-Luc2 and 61 GL261-AkaLuc cells in vitro at SNR = 5. For image-guided capabilities, we present BLT-guided 5-arc, BLT-guided 2-field box, and BLI-guided single-field plans. The high conformal 5-arc plan fully covers gross tumor volume (GTV) at prescribed dose with minimal normal tissue exposure from moderate to high dose range, while the simplified, high-throughput BLT-guided 2-field box achieves 100% GTV coverage but results in larger normal tissue exposure. The choice of the planning strategy should therefore depend on the specific requirements for radiation accuracy and experimental throughput. Moreover, we compared MuriGlo's tumor localization accuracy for widely used irradiators, SARRP and SmART+. The localization accuracy of MuriGlo for both SARRP and SmART+ irradiators is < 1 mm with GTV coverage > 97%. This universal, BLT-guided platform enables plug-and-play integration with commercial irradiators, supporting functional image guidance and enhancing high-precision preclinical radiation research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.